Search Results
Novo Nordisk CEO on Wegovy, Ozempic Supplies and Pricing
Novo Nordisk CEO defends high price off Ozempic and Wegovy
NBC News Exclusive: Ozempic and Wegovy Novo Nordisk CEO speaks out on high prices, drug shortages
The CEO Behind Ozempic, Wegovy and Europe's Most Valuable Company
Novo Nordisk CEO on Wegovy, Ozempic, Profit Forecast, US Market
Ozempic, Wegovy Really Good Value: Novo Nordisk CEO
Novo Nordisk CEO on Q4 results, soaring demand for Wegovy and Ozempic
How Ozempic And Wegovy Accidentally Made Novo Nordisk A $400B Company
Novo Nordisk CEO on Catalent, Ozempic and Wegovy
US Wegovy Supply to Expand ‘Gradually’: Novo Nordisk CEO
Novo Nordisk CEO on product pricing: Our numbers are 'declining year-on-year'
Weight-Loss Drugs Ozempic, Wegovy Propel Novo Nordisk Into Spotlight